Dr. Olesja Bondarenko from the Laboratory of Environmental Toxicology has joined the European Network of Vaccine Adjuvants (ENOVA), which brings together European experts and stakeholders working in different areas of adjuvant and vaccine research and development. ENOVA is funded by COST through the EU Framework Programme Horizon 2020 and is coordinated by the Vaccine Formulation Institute.

The goals of the network are to facilitate communication and to exchange of information on adjuvants and vaccine formulation among its members, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants and vaccines. Currently organizations from 28 countries joined ENOVA.

Please visit the project website for further information: www.enova-adjuvant.eu

The conference on “Innovation in the Research of Environmental Protection” in commemoration of the 70th anniversary of Professor Henri-Charles Dubourguier will be held in Estonian University of Life Sciences on February 7th, 2018.

Find more information and register to the conference in here, additional information also available in Facebook.

On November 16th-17th, 2017 the joint seminar of the COST AMICI (Anti-MIcrobial Coating Innovations to Prevent Infectious Diseases, 2016-2020) Network Core Group and the Working Group 3 was held in the National Institute of Chemical Physics and Biophysics. The scientific programme of WG3 Meeting in Tallinn was devoted to development and spreading microbial antibiotic resistance – one of the most urgent medial problems worldwide as antimicrobial coatings (AMCs) that should keep bacteria away or inhibit their growth, can also favour the emergence of microbial resistance to both the coating materials as well as to the traditional antibiotics. The chair of the seminar was dr. Anne Kahru, the head of the WG3 on risk-benefit analysis for the environmental aspects of the project and the antimicrobial coatings and the Head of the Laboratory of Environmental Toxiology.

Lectures were given by prof. Tanel Tenson (University of Tartu), prof. Irja Lutsar (University of Tartu), dr. Pille Märtin (Western Tallinn Hospital, Estonian Health Board), dr. Siiri Kõljalg (University of Tartu, Tartu University Hospital), dr. Theofilos Papadopoulos (Greece), dr. Maria Olívia Pereira ((University of Minho, Braga, Portugal) ja dr. Martijn Riool (University of Amsterdam, The Netherlands).

Tiina Titma defended her PhD Thesis entitled “Cytotoxicity of Metal-based Nanoparticles in Epithelial Barrier Models” on May 23, 2017 at Tallinn University.

Supervisors: